白参菌在制备治疗二型糖尿病药物中的应用

By optimizing the extraction process of Gynostemma pentaphyllum, and utilizing cyclodextrin inclusion complex and sodium citrate-EDTA composite solution, Gynostemma pentaphyllum extract was prepared, which solved the problem of insufficient application of Gynostemma pentaphyllum in the treatment of type 2 diabetes in existing technologies, and achieved significant therapeutic and preventive effects.

CN121059656BActive Publication Date: 2026-07-17PENGJUN (GUANGZHOU) BIOTECHNOLOGY CO LTD
View PDF 1 Cites 0 Cited by

Patent Information

Authority / Receiving Office
CN · China
Patent Type
Patents(China)
Current Assignee / Owner
PENGJUN (GUANGZHOU) BIOTECHNOLOGY CO LTD
Filing Date
2025-10-09
Publication Date
2026-07-17

Smart Images

  • Figure CN121059656B_ABST
    Figure CN121059656B_ABST
Patent Text Reader

Abstract

本发明公开了一种白参菌在制备治疗二型糖尿病药物中的应用，属于药学技术领域。所述治疗二型糖尿病药物的活性成分为白参菌提取物，所述白参菌提取物的制备方法为以白参菌为原料，通过酶解和微波辅助的方法进行提取，然后经过乙醇沉淀和喷雾干燥，即得。本发明基于糖尿病小鼠模型，通过监测小鼠血糖含量方面，发现白参菌对二型糖尿病有预防治疗作用，证明白参菌对二型糖尿病具有确切的疗效。本发明所制备的白参菌提取物具有安全高效特点，对二型糖尿病药物具有潜在的开发价值，并且本发明提取物为天然制剂，值得推广。
Need to check novelty before this filing date? Find Prior Art